ProCE Banner Activity

PREOPANC: Phase III Study of Preoperative Radiochemotherapy vs Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer

Slideset Download
Conference Coverage
Neoadjuvant treatment extended OS, DFS, and improved R0 resection rate vs adjuvant treatment in patients undergoing surgery for pancreatic cancer.

Released: June 11, 2018

Expiration: June 10, 2019

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Astellas Text

AstraZeneca

Celgene

Eisai

Genentech TEXT Only

Janssen

Merck Oncology

Seagen